The impact of season, environmental temperature and humidity on Raynaud phenomenon in an Australian systemic sclerosis cohort

Systemic Sclerosis

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

J Autoimmun

Chaigne B, Bense A, Aubourg F, Agard C, Allanore Y, Berezne A, Pugnet G, Hachulla E, Cottin V, Hot A, Dunogue B, Kanagaratnam A, Palat S, Lescoat A, Berthier S, Chatelus E, Rivière S, Launay D, Truchetet ME, Dinh-Xuan AT, Mouthon L, French Systemic Sclerosis Network

doi: 10.1016/j.jaut.2025.103391

Systemic Sclerosis

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Rheumatology (Oxford)

Goldman NR, Nihtyanova SI, Beesley CF, Wells AU, Denton CP, Renzoni EA, Mageed R, Ong VH

doi: 10.1093/rheumatology/keaf006

Systemic Sclerosis

Fatigue levels and associated factors in systemic sclerosis: a cross-sectional study of 2,385 SPIN Cohort participants

Rheumatology (Oxford)

Kwakkenbos L, Levis B, Henry RS, Virgili-Gervais G, Carrier ME, Bartlett SJ, Gietzen A, Gottesman K, Guillot G, Lawrie-Jones A, Hummers LK, Malcarne VL, Mayes MD, Richard M, Wojeck RK, Worron-Sauvé M, Hudson M, Mouthon L, Benedetti A, Thombs BD

doi: 10.1093/rheumatology/keae570

Systemic SclerosisFurther Publications Immunology

COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study

Semin Arthritis Rheum

Lakin KS, Wu Y, Gordon JK, Kwakkenbos L, Carrier ME, Henry RS, Denton CP, Mouthon L, Spiera RF, Thombs BD, SPIN COVID-19 Vaccination Patient Advisory Team, SPIN Investigators

doi: 10.1016/j.semarthrit.2024.152453

Systemic Sclerosis

Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

Rheumatology (Oxford)

Roth E, Bruni C, Petelytska L, Becker MO, Dobrota R, Jordan S, Mihai C, Muraru S, Carreira PE, De Vries-Bouwstra J, Braun-Moscovici Y, Liakouli V, Moroncini G, Bergmann C, Mouthon L, Denton CP, De Santis M, Cauli A, Adler S, Bernardino V, Truchetet ME, Vonk M, Del Galdo F, Hoffmann-Vold AM, Distler O, Elhai M, EUSTAR collaborators

doi: 10.1093/rheumatology/keaf016

Systemic Lupus Erythematosus

Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Semin Arthritis Rheum

González LA, Harvey GB, Quintana R, Pons-Estel GJ, Ugarte-Gil MF, Vásquez G, Catoggio LJ, García MA, Borba EF, Da Silva NA, Brenol JCT, Toledano MG, Massardo L, Neira O, Pascual-Ramos V, Amigo MC, Barile-Fabris LA, Torre IG, Alfaro-Lozano J, Segami MI, Chacón-Díaz R, Esteva-Spinetti MH, Iglesias-Gamarra A, Alarcón GS, Pons-Estel BA

doi: 10.1016/j.semarthrit.2024.152568

Systemic Lupus ErythematosusSystemic Sclerosis

Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Rheumatology (Oxford)

Patasova K, Dehara M, Mantel Ä, Bixo M, Arkema E, Holmqvist M

doi: 10.1093/rheumatology/keaf004

Systemic Sclerosis

Racial variability in immune responses only partially explains differential systemic sclerosis disease severity

Ann Rheum Dis

Kuchinad KE, Kim JS, Woods A, Leatherman G, Gutierrez-Alamillo L, Mayes MD, Domsic R, Ramos PS, Silver RM, Varga J, Saketkoo LA, Kafaja S, Shanmugan VK, Gordon J, Chung L, Bernstein EJ, Gourh P, Boin F, Kastner DL, Zeger SL, Casciola-Rosen L, Wigley FM, Shah AA

doi: 10.1136/ard-2023-225458

Systemic Sclerosis

Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study

Rheumatology (Oxford)

De Luca G, De Lorenzis E, Campochiaro C, Cacciapaglia F, Del Papa N, Zanatta E, Airò P, Lazzaroni MG, Giuggioli D, De Santis M, Alonzi G, Stano S, Binda M, Moccaldi B, Tonutti A, Cavalli S, Batani V, Natalello G, Iannone F, D'Agostino MA, Dagna L, Matucci-Cerinic M, Bosello SL

doi: 10.1093/rheumatology/keae280

Related content

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Fatigue levels and associated factors in systemic sclerosis: a cross-sectional study of 2,385 SPIN Cohort participants

COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study

Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Racial variability in immune responses only partially explains differential systemic sclerosis disease severity

Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study